PER2 and neoplasm: Rhythms of drug sensitivity were similarly dampened in cervical carcinoma cells (C33A) that carry an inactivating mutation in the retinoblastoma (RB) tumor suppressor and lack cellular oscillations of Per2 promoter–driven luciferase (pPer2-dLuc) (Fig. 2, E to G).